Financhill
Sell
39

SAFS Quote, Financials, Valuation and Earnings

Last price:
$0.0000
Seasonality move :
104.58%
Day range:
$0.0015 - $0.0015
52-week range:
$0.0000 - $0.0015
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
--
P/B ratio:
--
Volume:
20K
Avg. volume:
348.2K
1-year change:
-100%
Market cap:
--
Revenue:
--
EPS (TTM):
--

Analysts' Opinion

  • Consensus Rating
    No consensus rating exists at this time due to lack of analyst coverage.
  • Price Target Downside
    No price target exists because of limited analyst coverage.
  • Price Target Upside
    Similarly, at this time, analysts have not provided a price target so downside risk can't be assessed accurately at this time.

Fair Value

  • According to the consensus of 0 analysts, Safer Shot has -- downside to fair value with a price target of -- per share.

SAFS vs. S&P 500

  • Over the past 5 trading days, Safer Shot has overperformed the S&P 500 by 147546.66% suggesting its relative strength compared to the major market average is strong at this time.

Share Buyback

  • Safer Shot does not have a share repurchase program in place at this time. The scale of a buyback program can materially affect share price and usually results in a higher earnings per share, all else being equal, when the share count drops.

Revenue Growth

  • Safer Shot has grown year-over-year revenues for 0 quarters straight. In the most recent quarter Safer Shot reported revenues of --.

Earnings Growth

  • Safer Shot has grown year-over-year earnings for 0 quarters straight. In the most recent quarter Safer Shot reported earnings per share of --.
Enterprise value:
--
EV / Invested capital:
--
Price / LTM sales:
--
EV / EBIT:
--
EV / Revenue:
--
PEG ratio (5yr expected):
--
EV / Free cash flow:
--
Price / Operating cash flow:
--
Enterprise value / EBITDA:
--
Gross Profit (TTM):
--
Return On Assets:
--
Net Income Margin (TTM):
--
Return On Equity:
--
Return On Invested Capital:
--
Operating Margin:
--
Trailing 12 Months Fiscal Quarters
Period Ending 2023-01-08 2024-01-08 2024-01-08
Income Statement
Revenue -- -- -- -- --
Gross Profit -- -- -- -- --
Operating Income -- -- -- -- --
EBITDA -- -- -- -- --
Diluted EPS -- -- -- -- --
Period Ending 2021-01-08 2022-01-08 2023-01-08 2024-01-08
Balance Sheet
Current Assets -- -- -- -- --
Total Assets -- -- -- -- --
Current Liabilities -- -- -- -- --
Total Liabilities -- -- -- -- --
Total Equity -- -- -- -- --
Total Debt -- -- -- -- --
Trailing 12 Months Fiscal Quarters
Period Ending 2023-01-08 2024-01-08 2024-01-08
Cash Flow Statement
Cash Flow Operations -- -- -- -- --
Cash From Investing -- -- -- -- --
Cash From Financing -- -- -- -- --
Free Cash Flow -- -- -- -- --
SAFS
Sector
Market Cap
--
$764.9M
Price % of 52-Week High
--
79%
Dividend Yield
0%
0%
Shareholder Yield
--
2.32%
1-Year Price Total Return
-100%
-0.45%
Beta (5-Year)
-88.091
0.915
Dividend yield:
0%
Annualized payout:
$0.00
Payout ratio:
--
Growth streak:
0 years

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Technicals

8-day SMA
Buy
Level $0.0002
200-day SMA
Buy
Level $0.0000
Bollinger Bands (100)
Buy
Level 0 - 0
Chaikin Money Flow
Buy
Level 668.9M
20-day SMA
Buy
Level $0.0001
Relative Strength Index (RSI14)
Buy
Level 100.0000
ADX Line
Buy
Level 7.1429
Williams %R
Buy
Level -100
50-day SMA
Buy
Level $0.0000
MACD (12, 26)
Buy
Level 0.0001
25-day Aroon Oscillator
Buy
Level 88
On Balance Volume
Neutral
Level 2.4B

Financial Scores

--
Altman Z-Score (Annual)
Level (--)
--
CA Score (Annual)
Level (--)
--
Beneish M-Score (Annual)
Level (--)
--
Momentum Score
Level (--)
--
Ohlson Score
Level (--)
--
Piotroski F Score (Annual)
Level (--)
--
Quality Ratio Score
Level (--)
--
Fundamental Score
Level (--)

Revenue Forecast

Earnings per Share Forecast

Company Profile

Safer Shot Inc is engaged in developing a line of non-lethal weapons that utilize a proprietary kinetic projectile cartridge. The weapon system incapacitates an assailant without the risk of inflicting serious injury or death. The silicon coated projectile ruptures on impact producing a putty-like substance that disables a target without breaking the skin or entering the body. Its products include The Safer Shot Bouncer Cartridge System, Safer Shot Bouncer M-22, Safer Shot Mini and Safer Shot Bouncer M-11.

Stock Forecast FAQ

In the current month, SAFS has received 0 Buy ratings 0 Hold ratings, and 0 Sell ratings. The SAFS average analyst price target in the past 3 months is --.

  • Where Will Safer Shot Stock Be In 1 Year?

    According to analysts, the consensus estimate is that Safer Shot share price will drop to -- per share over the next 12 months.

  • What Do Analysts Say About Safer Shot?

    Analysts are divided on their view about Safer Shot share price and where it will be in the next 12 months. The majority of analysts rate the stock a Buy. However, a smaller subset of analysts suggest that Safer Shot is a Sell and believe this share price will rise from its current level to --.

  • What Is Safer Shot's Price Target?

    The price target for Safer Shot over the next 1-year time period is forecast to be -- according to 0 Wall Street analysts, 0 of them rate the stock a Buy, 0 rate the stock a Sell, and 0 analysts rate the stock a Hold.

  • Is SAFS A Buy, Sell Or Hold?

    According to Wall Street analysts, the consensus rating for Safer Shot is a --. 0 of 0 analysts rate the stock a -- at this time.

  • How Can I Buy Shares Of SAFS?

    You can purchase shares of Safer Shot via an online brokerage firm such as TD Ameritrade.com, thinkorswim.com, e-trade.com, TastyTrade.com, or Schwab.com. Many other digital online brokerages exist such as RobinHood and Webull where you can purchase Safer Shot shares.

  • What Is The Safer Shot Share Price Today?

    Safer Shot was last trading at $0.0000 per share. This represents the most recent stock quote for Safer Shot. Yesterday, Safer Shot closed at $0.0000 per share.

  • How To Buy Safer Shot Stock Online?

    In order to purchase Safer Shot stock online, open a brokerage account, deposit funds into the account, and select an order type to purchase shares whether it be market or limit.

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Popular

Is SCHD a Good ETF to Buy?
Is SCHD a Good ETF to Buy?

With around $65.7 billion in net assets, Schwab’s US Dividend…

Is NAIL a Good ETF to Buy?
Is NAIL a Good ETF to Buy?

If you’re thinking about buying the NAIL ETF, this article…

3 High Dividend Dow Jones Stocks
3 High Dividend Dow Jones Stocks

Thanks to surging stock prices over the past two years,…

Stock Ideas

Sell
42
Is AAPL Stock a Buy?

Market Cap: $3.7T
P/E Ratio: 40x

Buy
59
Is NVDA Stock a Buy?

Market Cap: $3.7T
P/E Ratio: 125x

Sell
46
Is MSFT Stock a Buy?

Market Cap: $3.2T
P/E Ratio: 36x

Alerts

Sell
50
NARI alert for Jan 7

Inari Medical [NARI] is up 22.25% over the past day.

Buy
70
PDEX alert for Jan 7

Pro-Dex [PDEX] is down 10.89% over the past day.

Buy
52
ALCO alert for Jan 7

Alico [ALCO] is down 3.89% over the past day.

THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS

Show me the best stock